BFS
AMGN icon

Bradley Foster & Sargent’s Amgen AMGN Stock Holding History

Bradley Foster & Sargent’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95M Sell
14,069
-414
-3% -$148K 0.08% 152
2025
Q4 		$4.74M Buy
14,483
+69
+0.5% +$21.9K 0.07% 159
2025
Q3 		$4.07M Sell
14,414
-1,336
-8% -$387K 0.06% 170
2025
Q2 		$4.4M Buy
15,750
+1,631
+12% +$462K 0.07% 165
2025
Q1 		$4.4M Sell
14,119
-1,375
-9% -$406K 0.08% 156
2024
Q4 		$4.04M Sell
15,494
-705
-4% -$209K 0.07% 161
2024
Q3 		$5.22M Sell
16,199
-44
-0.3% -$14.4K 0.09% 148
2024
Q2 		$5.08M Buy
16,243
+424
+3% +$125K 0.09% 145
2024
Q1 		$4.5M Sell
15,819
-232
-1% -$67.9K 0.08% 153
2023
Q4 		$4.62M Buy
16,051
+692
+5% +$189K 0.09% 148
2023
Q3 		$3.41M Hold
15,359
– – 0.07% 168
2023
Q2 		$3.41M Buy
15,359
+2,011
+15% +$467K 0.07% 168
2023
Q1 		$3.23M Sell
13,348
-39
-0.3% -$9.57K 0.08% 158
2022
Q4 		$3.52M Sell
13,387
-214
-2% -$57.4K 0.09% 141
2022
Q3 		$3.07M Sell
13,601
-3
-0% -$727 0.08% 148
2022
Q2 		$3.31M Buy
13,604
+1,137
+9% +$279K 0.09% 147
2022
Q1 		$3.02M Buy
12,467
+686
+6% +$158K 0.06% 166
2021
Q4 		$2.65M Buy
11,781
+1,366
+13% +$288K 0.05% 178
2021
Q3 		$2.21M Buy
10,415
+354
+4% +$81.5K 0.05% 177
2021
Q2 		$2.45M Sell
10,061
-496
-5% -$122K 0.06% 169
2021
Q1 		$2.63M Buy
10,557
+3,997
+61% +$954K 0.07% 162
2020
Q4 		$1.51M Sell
6,560
-193
-3% -$44.5K 0.04% 192
2020
Q3 		$1.72M Buy
+6,753
New +$1.67M 0.05% 169
2020
Q1 		$1.42M Sell
6,985
-123
-2% -$26.9K 0.06% 158
2019
Q4 		$1.71M Buy
7,108
+171
+2% +$37.7K 0.05% 177
2019
Q3 		$1.34M Sell
6,937
-425
-6% -$81.6K 0.04% 191
2019
Q2 		$1.36M Sell
7,362
-6,383
-46% -$1.14M 0.04% 193
2019
Q1 		$2.61M Sell
13,745
-846
-6% -$162K 0.09% 142
2018
Q4 		$2.84M Buy
14,591
+51
+0.4% +$9.95K 0.11% 133
2018
Q3 		$3.01M Sell
14,540
-350
-2% -$69K 0.1% 145
2018
Q2 		$2.75M Buy
14,890
+7,371
+98% +$1.3M 0.1% 149
2018
Q1 		$1.28M Buy
7,519
+255
+4% +$46.8K 0.05% 195
2017
Q4 		$1.26M Sell
7,264
-318
-4% -$56.3K 0.05% 196
2017
Q3 		$1.41M Buy
7,582
+1,510
+25% +$268K 0.05% 186
2017
Q2 		$1.05M Buy
6,072
+591
+11% +$96.1K 0.04% 201
2017
Q1 		$899K Buy
5,481
+231
+4% +$38.4K 0.04% 206
2016
Q4 		$768K Sell
5,250
-739
-12% -$111K 0.03% 224
2016
Q3 		$999K Buy
5,989
+471
+9% +$79.6K 0.04% 193
2016
Q2 		$840K Buy
5,518
+1,205
+28% +$187K 0.04% 201
2016
Q1 		$647K Buy
4,313
+21
+0.5% +$3.12K 0.03% 229
2015
Q4 		$697K Sell
4,292
-200
-4% -$31.4K 0.03% 214
2015
Q3 		$621K Sell
4,492
-200
-4% -$31.5K 0.03% 222
2015
Q2 		$720K Sell
4,692
-2,057
-30% -$330K 0.03% 227
2015
Q1 		$1.08M Sell
6,749
-183
-3% -$28.8K 0.05% 192
2014
Q4 		$1.1M Buy
6,932
+210
+3% +$32.7K 0.05% 185
2014
Q3 		$944K Buy
6,722
+1,991
+42% +$260K 0.04% 199
2014
Q2 		$560K Sell
4,731
-220
-4% -$25.5K 0.03% 232
2014
Q1 		$611K Buy
4,951
+438
+10% +$53.1K 0.03% 226
2013
Q4 		$515K Buy
4,513
+10
+0.2% +$1.14K 0.03% 246
2013
Q3 		$504K Buy
4,503
+510
+13% +$55.3K 0.03% 232
2013
Q2 		$394K Buy
+3,993
New +$414K 0.02% 246

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bradley Foster & Sargent's AMGN Position: Q1 2026 in Review

Bradley Foster & Sargent reduced its Amgen (AMGN) stake by 2.9% in Q1 2026, selling an estimated $148K and leaving 14,069 shares worth $4.95M. The position accounts for 0.08% of the portfolio, ranked #152.

Bradley Foster & Sargent first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.22M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bradley Foster & Sargent held 14,069 shares of Amgen worth $4.95M as of Q1 2026.
  • Bradley Foster & Sargent sold 414 Amgen shares in Q1 2026, an estimated $148K.
  • Amgen made up 0.08% of Bradley Foster & Sargent's portfolio in Q1 2026, its #152 holding.
  • Bradley Foster & Sargent first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Bradley Foster & Sargent's Amgen position peaked at $5.22M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.